Foundation Funds Two New Studies on IMHA in Dogs
MEDIA ALERT: DENVER/June 27, 2024 — Morris Animal Foundation has announced the approval of funding for two new studies focused on immune-mediated hemolytic anemia, a deadly blood disorder of dogs.
Displaying 1 - 10 of 12 results
Are There Subtypes of IMHA In Dogs?
Researchers will study whether there are subtypes of IMHA and whether those subtypes have different prognoses and optimal therapy.
Finding Better Therapies for Dogs with IMHA
Researchers will assess how the immune system goes wrong in dogs with IMHA, and the team will study how individual dogs respond to medications available for treatment.
Immune-Mediated Anemia – A Little Known But Deadly Disease of Dogs
August 6, 2020 – Immune-mediated hemolytic anemia occurs when the body suddenly perceives red blood cells as foreign invaders. Learn more about how it effects dogs.
New Fundraiser Takes Aim at Deadly Immune Disease
May 1, 2023 — Immune-mediated hemolytic anemia is a serious, but underfunded, disease of dogs. A newly created fundraiser hopes to improve the odds for dogs suffering from this condition by supporting new research studies.
Reducing Blood Clots in Dogs with Immune-Mediated Hemolytic Anemia (IMHA)
Researchers will improve techniques for monitoring anticoagulant therapy and preventing blood clot complications in dogs with immune-mediated hemolytic anemia.
Morris Animal Foundation Opens Call for Canine IMHA-Focused Research
August 23, 2023 — Morris Animal Foundation is now accepting research proposals that will lead to a further understanding of canine immune-mediated hemolytic anemia.
Your Gifts in Action - Summer 2020
July 1, 2020 – A clinical trial for deadly blood disorder and a promising oral cancer therapy are a just few of the highlighted studies funded by Morris Animal Foundation.
Evaluating a New Treatment for a Deadly Blood Disorder
Researchers will evaluate a novel drug as a potential new treatment for immunemediated hemolytic anemia, a serious and fatal blood disorder in dogs.
Searching for Clues to Improve Treatment for Deadly Blood Disorder
Researchers will investigate a potential cause of red blood cell destruction in immune-mediated hemolytic anemia to inform the development of targeted treatments for this deadly autoimmune disease.